Pancreatic Cancer Research

ResearcherActive in the last 2 years

Hong‐Ming Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2206-3470; OpenAlex author ID A5006779280. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. Early evidence of the efficacy of TCR-T therapy targeting the G12V mutation in patients with advanced pancreatic cancer. Co-author DOI 10.1016/j.ymthe.2026.06.010↗
  2. IND-Enabling Studies for a TCR-T Targeting a Pancreatic Cancer KRASG12V Mutation. Last author DOI 10.1158/1078-0432.ccr-24-3086↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuhong Li · 1 shared paper, 2026 · strength 0.50
  2. Xinbo Wang · 1 shared paper, 2025 · strength 0.19
  3. Sizhen Wang · 1 shared paper, 2025 · strength 0.19
  4. Rongxi Shen · 1 shared paper, 2025 · strength 0.19
  5. Yonghao Ouyang · 1 shared paper, 2025 · strength 0.19
  6. Yimin Chen · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.